WASHINGTON – U.S. health officials are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related drugs.
For now, the Food and Drug Administration said patients can continue taking their medications.
The agency said Friday it has detected a “probable” cancer-causing chemical in the medications, which are sold as both prescription and over-the-counter treatments.
FDA officials said the amount of the contaminant barely exceeds levels found in common foods. But the same chemical has been linked to dozens of recalls of blood pressure drugs in the past year. The FDA is still investigating that issue and last month sanctioned a manufacturing plant in India that makes some of the medications.
Roughly 80 percent of the ingredients used in U.S. drugs are manufactured overseas.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.